162 related articles for article (PubMed ID: 16940108)
1. Combination of suboptimal doses of inhibitors targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to Miltefosine by inhibiting drug efflux.
Pérez-Victoria JM; Cortés-Selva F; Parodi-Talice A; Bavchvarov BI; Pérez-Victoria FJ; Muñoz-Martínez F; Maitrejean M; Costi MP; Barron D; Di Pietro A; Castanys S; Gamarro F
Antimicrob Agents Chemother; 2006 Sep; 50(9):3102-10. PubMed ID: 16940108
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.
Pérez-Victoria FJ; Sánchez-Cañete MP; Seifert K; Croft SL; Sundar S; Castanys S; Gamarro F
Drug Resist Updat; 2006; 9(1-2):26-39. PubMed ID: 16814199
[TBL] [Abstract][Full Text] [Related]
3. Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin.
Abu Ajaj K; Graeser R; Kratz F
Breast Cancer Res Treat; 2012 Jul; 134(1):117-29. PubMed ID: 22228402
[TBL] [Abstract][Full Text] [Related]
4. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
Chufan EE; Kapoor K; Ambudkar SV
Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
[TBL] [Abstract][Full Text] [Related]
5. Coadministration of P-glycoprotein modulators on loperamide pharmacokinetics and brain distribution.
Montesinos RN; Moulari B; Gromand J; Beduneau A; Lamprecht A; Pellequer Y
Drug Metab Dispos; 2014 Apr; 42(4):700-6. PubMed ID: 24398461
[TBL] [Abstract][Full Text] [Related]
6. Dihydro-beta-agarofuran sesquiterpenes: a new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania.
Cortés-Selva F; Jiménez IA; Munoz-Martínez F; Campillo M; Bazzocchi IL; Pardo L; Ravelo AG; Castanys S; Gamarro F
Curr Pharm Des; 2005; 11(24):3125-39. PubMed ID: 16178749
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents.
Pérez-Victoria JM; Di Pietro A; Barron D; Ravelo AG; Castanys S; Gamarro F
Curr Drug Targets; 2002 Aug; 3(4):311-33. PubMed ID: 12102602
[TBL] [Abstract][Full Text] [Related]
8. A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors.
Planting AS; Sonneveld P; van der Gaast A; Sparreboom A; van der Burg ME; Luyten GP; de Leeuw K; de Boer-Dennert M; Wissel PS; Jewell RC; Paul EM; Purvis NB; Verweij J
Cancer Chemother Pharmacol; 2005 Jan; 55(1):91-9. PubMed ID: 15565444
[TBL] [Abstract][Full Text] [Related]
9. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.
Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
Drug Deliv; 2012 Nov; 19(8):363-70. PubMed ID: 23030458
[TBL] [Abstract][Full Text] [Related]
10. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.
Verma NK; Singh G; Dey CS
Exp Parasitol; 2007 May; 116(1):1-13. PubMed ID: 17161839
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
[TBL] [Abstract][Full Text] [Related]
12. Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania.
Pérez-Victoria JM; Bavchvarov BI; Torrecillas IR; Martínez-García M; López-Martín C; Campillo M; Castanys S; Gamarro F
Antimicrob Agents Chemother; 2011 Aug; 55(8):3838-44. PubMed ID: 21646479
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice.
Godinho JL; Simas-Rodrigues C; Silva R; Ürmenyi TP; de Souza W; Rodrigues JC
Int J Antimicrob Agents; 2012 Apr; 39(4):326-31. PubMed ID: 22226653
[TBL] [Abstract][Full Text] [Related]
14. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.
Dorlo TP; Balasegaram M; Beijnen JH; de Vries PJ
J Antimicrob Chemother; 2012 Nov; 67(11):2576-97. PubMed ID: 22833634
[TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.
Dantzig AH; Shepard RL; Cao J; Law KL; Ehlhardt WJ; Baughman TM; Bumol TF; Starling JJ
Cancer Res; 1996 Sep; 56(18):4171-9. PubMed ID: 8797588
[TBL] [Abstract][Full Text] [Related]
16. Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier.
Choo EF; Kurnik D; Muszkat M; Ohkubo T; Shay SD; Higginbotham JN; Glaeser H; Kim RB; Wood AJ; Wilkinson GR
J Pharmacol Exp Ther; 2006 Jun; 317(3):1012-8. PubMed ID: 16537797
[TBL] [Abstract][Full Text] [Related]
17. Interactions of the multidrug resistance modulators tariquidar and elacridar and their analogues with P-glycoprotein.
Pajeva IK; Sterz K; Christlieb M; Steggemann K; Marighetti F; Wiese M
ChemMedChem; 2013 Oct; 8(10):1701-13. PubMed ID: 23943604
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice.
Bardelmeijer HA; Ouwehand M; Beijnen JH; Schellens JH; van Tellingen O
Invest New Drugs; 2004 Aug; 22(3):219-29. PubMed ID: 15122069
[TBL] [Abstract][Full Text] [Related]
19. Effects of miltefosine on membrane permeability and accumulation of [99mTc]-hexakis-2-methoxyisobutyl isonitrile, 2-[18F]fluoro-2-deoxy-D-glucose, daunorubucin and rhodamine123 in multidrug-resistant and sensitive cells.
Márián T; Balkay L; Trón L; Krasznai ZT; Szabó-Péli J; Krasznai Z
Eur J Pharm Sci; 2005 Apr; 24(5):495-501. PubMed ID: 15784339
[TBL] [Abstract][Full Text] [Related]
20. Functional Validation of ABCA3 as a Miltefosine Transporter in Human Macrophages: IMPACT ON INTRACELLULAR SURVIVAL OF LEISHMANIA (VIANNIA) PANAMENSIS.
Dohmen LC; Navas A; Vargas DA; Gregory DJ; Kip A; Dorlo TP; Gomez MA
J Biol Chem; 2016 Apr; 291(18):9638-47. PubMed ID: 26903515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]